mTOR信号通路在质母细胞瘤及其干细胞中的复杂作用
Austin B Carpenter1, Ariel Sacknovitz1, Simon Hanft1
1Department of Neurosurgery, New York Medical College/Westchester Medical Center, Valhalla, 10595, New York, USA.
猛素 (mTOR) 途径失调的哺乳动物目标驱动着质母细胞瘤 (GBM) 的生长和复发. 双重mTOR抑制剂在向GBM及其癌症干细胞方面表现有前途,提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 哺乳动物目标拉巴胺素 (mTOR) 途径的异常信号,特别是mTORC1和mTORC2,与各种癌症的瘤发生有关,包括质母细胞瘤 (GBM).
- 在GBM中,PI3K/AKT/mTOR信号级联经常因瘤抑制剂PTEN的丧失而失调.
- 癌症干细胞 (CSCs) 在GBM中有助于疾病的发展,进展和复发,特别是那些在周围瘤区域发现的癌症干细胞.
研究的目的:
- 审查mTOR抑制剂在治疗质母细胞瘤 (GBM) 中的治疗潜力.
- 突出mTOR抑制剂在向GBM癌症干细胞 (CSCs) 和解决疾病复发中的作用.
- 强调了解周瘤区域对于控制GBM复发的重要性.
主要方法:
- 对GBM中mTOR信号的现有文献的审查.
- 针对mTORC1和mTORC2.2的ATP竞争性双重抑制剂的研究.
- 分析mTOR抑制剂对CSC自我更新和GBM生长的影响.
主要成果:
- 双重mTOR抑制剂通过抑制S6K和4E-BP1 (mTORC1) 和AKT (mTORC2) 等关键下游基质来抑制GBM的生长和迁移.
- 这些抑制剂在改变GBM癌症干细胞 (CSC) 的自我更新和生长方面表现出有效性.
- 了解周周瘤微环境对于管理GBM复发至关重要.
结论:
- mTOR抑制剂代表了对GBM的有希望的治疗策略,向瘤细胞和CSC.
- 对mTORC1和mTORC2的双抑制为GBM治疗提供了与拉帕米辛类似物相比的潜在优势.
- 针对CSC和周瘤区域对于克服GBM复发和改善患者的治疗结果至关重要.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
07:11Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture
Published on: August 25, 2022
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
